Cyclacel Pharmaceuticals, Inc. (BGMS)
NASDAQ
Cyclacel Pharmaceuticals, Inc. Revenue 2024–2025
Cyclacel Pharmaceuticals, Inc. annual/quarterly revenue history and growth rate from 2024 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Cyclacel Pharmaceuticals, Inc. revenue for the quarter ending March 31, 2026 was 778000.
- Cyclacel Pharmaceuticals, Inc. revenue for the twelve months ending March 31, 2026 was 1.5 M.
- Cyclacel Pharmaceuticals, Inc. annual revenue for 2025 was 747000, a 1637.21% increase from 2024.
- Cyclacel Pharmaceuticals, Inc. annual revenue for 2024 was 43000.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cyclacel Pharmaceuticals, Inc. Revenue — FAQ
Cyclacel Pharmaceuticals, Inc. (BGMS) revenue over the last 2 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclacel Pharmaceuticals, Inc.'s revenue?
Cyclacel Pharmaceuticals, Inc. (BGMS) reported revenue of $747,000 for fiscal 2025.
Where can I see BGMS's revenue history?
The chart and table above show Cyclacel Pharmaceuticals, Inc.'s revenue by year and by quarter, including the growth rate.